Counteracting autophagy overcomes resistance to everolimus in mantle cell lymphoma
Clinical Cancer Research, 08/10/2012
Clinical Article
Rosich L et al. – The results suggest that autophagy induction protects Mantle cell lymphoma (MCL) cells from Akt/mTOR targeting and counteracting autophagy may represent an attractive strategy for sensitizing MCL cells to everolimus–based therapy.



